Lite Strategy, Inc.
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $33.2M
- Price
- $0.9769
- % Change (Daily % change from the live per-ticker quote feed.)
- +0.59%
- Volume
- 98.1K
Quote data as of 6:10 AM ET
About
Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. The company was formerly known as MEI Pharma, Inc. and changed its name to Lite Strategy, Inc. in September 2025. Lite Strategy, Inc. was incorporated in 2000 and is based in San Diego, California.
Quick stats
Shares outstanding34.0M
Computed float31.7M
Float sourceUnknown
Cash runway (months)Unknown
Dilution risk—
Has warrants—
Has convertibles—
Active shelf (Shelf registration (e.g. Form S-3) currently in effect — the company is pre-cleared to issue and sell new shares quickly. A standing dilution risk.)—
Active ATM (At-the-market offering — a program to sell newly issued shares directly into the open market at prevailing prices, diluting existing holders over time.)—
Key info
SectorFinancial Services
IndustryAsset Management - Cryptocurrency
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0001262104
Websitehttps://www.litestrategy.com
AI Summary
AI-generated20d agominorneutraloperations updateLite Strategy to Attend Panel at Litecoin Foundation Summit in Amsterdam
Lite Strategy will participate in a featured panel at the Litecoin Foundation Summit in Amsterdam on June 22, 2026.
The panel, titled 'Litecoin's institutional opportunity,' will feature Board Members Charlie Lee and Joshua Riezman, moderated by Randi Hipper.
This marks the first appearance of a NASDAQ-listed digital asset treasury company at the annual event, highlighting the growing institutional adoption of Litecoin.